Lonza manufactures coronavirus vaccine for Moderna Lonza plans to start production of Moderna’s coronavirus vaccine in Switzerland before the end of…martin11.17.2020
Synendos raises 20 million Swiss francs Synendos Therapeutics has concluded a Series A financing round, raising 20 million Swiss francs. The…martin11.12.2020
ChemAxon establishes subsidiary in Basel ChemAxon develops software for application in the chemicals and biopharma industries. Now, the Hungarian company…martin11.06.2020
DSM strengthens the Basel Area life sciences cluster The global nutrition and health corporation Royal DSM is establishing a new innovation center at…martin11.05.2020
Canton of Jura looking towards robotics The canton of Jura has for quite some time been a hub for the precision…martin11.03.2020
Novartis agrees cooperation to fight Covid-19 A collaboration between Molecular Partners and Novartis has been announced. Molecular Partners will be responsible…martin10.29.2020
An intense and ambitious year for the Jura site of the Switzerland Innovation Park Basel Area Despite the coronavirus pandemic, which has delayed some projects, the Jura site of the Switzerland…annett10.23.2020
VectivBio secures investments totaling 110 million dollars The Basel-based biotechnology firm VectivBio has received a capital injection of 110 million US dollars…martin10.19.2020
Polyphor receives up to 18 million dollars for development of antibiotics The Allschwil-based company Polyphor has received a second funding award from the global consortium CARB-X…martin10.15.2020
DayOne Accelerator applications open We are excited to announce the opening of the call for the DayOne Accelerator, now in its 3rd year!10.02.2020